Plasma protein Z levels inversely correlate with plasma interleukin-6 levels in patients with acute leukemia and non-Hodgkin's lymphoma

Thrombosis Research

Volumn 94, Issue 2, 1999, Pages 131-134

  Ündar, Levent ^a   Karadogan, Ihsan ^a   Öztürk, Firuzan ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

Author keywords

Acute leukemia; Interleukin 1 ; Interleukin 6; Non Hodgkin's lymphoma; Protein Z; Tumor necrosis factor

Indexed keywords

FATTY ACID BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LARGE CELL LYMPHOMA; LYMPHOCYTOMA; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADULT; AGED; BLOOD PROTEINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERLEUKIN-1; INTERLEUKIN-6; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, MYELOCYTIC, ACUTE; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; STATISTICS, NONPARAMETRIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033560668     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(98)00210-2     Document Type: Article

References (17)

1. Broze G.J. Jr., Miletich J.P. Human protein Z. J Clin Invest. 73:1984;933-938.
2. Raczkowski C.A., Reichli M., Esmon C.T., Comp P.C. Protein Z is a negatively responding acute phase protein. Thromb Haemost. 69:1987;56.
3. Miletich J.P., Broze G.J. Jr. Human plasma protein Z antigen. Range in normal subjects and effect of warfarin therapy Blood. 69:1987;1580-1586.
4. Subramaniasivam R., Mauron T., Lammle B., Wuillemin W.A. Protein Z in healthy human individuals and in patients with a bleeding tendency. Br J Haematol. 102:1998;1219-1223.
5. Sehgal P.B. Interleukin-6. A regulator of plasma protein gene expression in hepatic and non-hepatic tissues Mol Biol Med. 7:1990;117-130.
6. Akira S., Hirano T., Tag T., Kishimoto T. Biology of multifunctional cytokines. IL-6 and related molecules (IL-1 and TNF) FASEB J. 4:1992;2860-2867.
7. Zhang X.G., Klein B., Bataill R. Interleukin-6 is a potent myeloma-cell growth factor in patients with aggressive multiple myeloma. Blood. 74:1989;11-13.
8. Shimizu S., Hirano T., Yoshioka R., Sugai S., Matsuda T., Taga T., Kishimoto T., Konda S. Interleukin-6 (B-cell stimulatory factor 2)-dependent growth of a Lennert's lymphoma-derived T-cell line (KT-3). Blood. 72:1988;1826-1828.
9. Steel D.M., Whitehead A.S. The major acute phase reactants. C-reactive protein, serum amyloid P component and serum amyloid A protein Immunol Today. 15:1994;81-88.
10. Baumann H., Gauldie J. The acute phase response. Immunol Today. 15:1994;74-80.
11. Margaglione M., Grandone E., Mancini F.P., Di Minno G. Genetic modulation of plasma fibrinogen concentrations. Possible importance of interleukin-6 J Thromb Thrombolysis. 3:1996;51-56.
12. Fong Y., Tracey K.J., Moldawer L.L., Hesse D.G., Monogue K.R., Kenney J.S., Lee A.T., Kuo G.C., Allison A.C., Lowry S.F., Cerami A. Antibodies to cachectin/tumor necrosis factor reduce interleukin 1β and interleukin 6 appearance during lethal bacteraemia. J Exp Med. 170:1989;1627-1633.
13. Baigrie R.J., Lamont P.M., Dallman M., Morris P.J. The release of interleukin-1β (IL-1) precedes that of interleukin-6 (IL-6) in patients undergoing major surgery. Lymphokine Cytokine Res. 10:1991;253-256.
14. Ulich T.R., Guo K., Remick D., Del Castillo J., Yin S. Endotoxin-induced cytokine gene expression in vivo. J Immunol. 146:1991;2316-2323.
15. Kemkes-Matthes B., Matthes K.J. A new bleeding disorder. Protein Z deficiency Thromb Haemost. 69:1993;1290.
16. Greten J., Kemkes-Matthes B., Nawroth P.P. Prothrombin complex concentrate contains protein Z and prevents bleeding in a patient with protein Z deficiency. Thromb Haemost. 74:1995;992-993.
17. Bertolino G., Gamba G., Torti P., Spedini P., Montani N., Mosconi E., Noris P., Balduini C.L. Plasma protein Z levels and haemostasis in patients with bleeding tendency of unknown origin. Thromb Haemost. 73:1995;1206.